165 related articles for article (PubMed ID: 31197028)
1. Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma.
Area C; Yen CJ; Chevez-Barrios P; Herzog C; Kan P; Zheng W; Lin F; Chintagumpala M; Gombos D; Chen SR
J Neurointerv Surg; 2019 Dec; 11(12):1273-1276. PubMed ID: 31197028
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.
Monroe EJ; Chick JFB; Stacey AW; Millard NE; Geyer JR; Ramoso LR; Ghodke BV; Hallam DK
Pediatr Radiol; 2021 Apr; 51(4):649-657. PubMed ID: 33231717
[TBL] [Abstract][Full Text] [Related]
3. Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.
Boddu SR; Abramson DH; Marr BP; Francis JH; Gobin YP
J Neurointerv Surg; 2017 Nov; 9(11):1107-1112. PubMed ID: 29030462
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose reduction in intra-arterial chemotherapy infusion for intraocular retinoblastoma.
Cooke DL; Stout CE; Kim WT; Hetts SW; Higashida RT; Halbach VV; Dowd CF; Gould RG
J Neurointerv Surg; 2014 Dec; 6(10):785-9. PubMed ID: 24385553
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
Abruzzo T; Abraham K; Karani KB; Geller JI; Vadivelu S; Racadio JM; Zhang B; Correa ZM
AJNR Am J Neuroradiol; 2021 Jan; 42(2):354-361. PubMed ID: 33361377
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma.
Qureshi AM; Davies LK; Patel PA; Rennie A; Robertson F
AJNR Am J Neuroradiol; 2019 Apr; 40(4):713-717. PubMed ID: 30872423
[TBL] [Abstract][Full Text] [Related]
7. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.
Pham CT; Blanc R; Lumbroso-Le Rouic L; Pistocchi S; Bartolini B; Piotin M
Neuroradiology; 2012 Aug; 54(8):845-8. PubMed ID: 22089977
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma.
Sweid A; El Naamani K; Sajja KC; Hammoud B; Knapp MD; Moylan DD; Joffe D; Morse CE; Habbal D; Weinberg JH; Tjoumakaris SI; Shields CL; Lezama DA; Lim LS; Dalvin LA; Rosenwasser R; Jabbour P
J Neurointerv Surg; 2021 Jul; 13(7):652-656. PubMed ID: 33122349
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact.
Guasti A; Leonini S; Bertelli E; Baldi R; Gennari P; Cioni S; Vallone IM; Romano DG; Casseri T; Guerrini L; La Rocca AE; Scala PGD; De Francesco S; Hadjistilianou T; Bracco S
Neuroradiology; 2019 Sep; 61(9):1083-1091. PubMed ID: 31332478
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up.
Bertelli E; Leonini S; Galimberti D; Moretti S; Tinturini R; Hadjistilianou T; De Francesco S; Romano DG; Vallone IM; Cioni S; Gennari P; Galluzzi P; Grazzini I; Rossi S; Bracco S
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1289-95. PubMed ID: 26915566
[TBL] [Abstract][Full Text] [Related]
11. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
12. Complications of intra-arterial chemotherapy for retinoblastoma.
Monroy JE; Orbach DB; VanderVeen D
Semin Ophthalmol; 2014; 29(5-6):429-33. PubMed ID: 25325870
[TBL] [Abstract][Full Text] [Related]
13. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma.
Sweid A; Hammoud B; Texakalidis P; Xu V; Shivashankar K; Baldassari MP; Das S; Tjoumakaris S; Shields CL; Ancona-Lezama D; Lim LS; Dalvin LA; Maamari DJ; Jabbour P
Neurosurgery; 2020 Oct; 87(5):956-963. PubMed ID: 32396190
[TBL] [Abstract][Full Text] [Related]
14. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned?
Vijayakrishnan R; Shields CL; Ramasubramanian A; Emrich J; Rosenwasser R; Shields JA
Arch Ophthalmol; 2010 Nov; 128(11):1427-31. PubMed ID: 21060044
[TBL] [Abstract][Full Text] [Related]
15. Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success.
Opitz M; Bos D; Deuschl C; Radbruch A; Zensen S; Sirin S; Forsting M; Bechrakis N; Biewald E; Bornfeld N; Ketteler P; Timmermann B; Stuschke M; Guberina M; Wetter A; Göricke S; Guberina N
Neuroradiology; 2021 Mar; 63(3):391-398. PubMed ID: 32862237
[TBL] [Abstract][Full Text] [Related]
16. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
17. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
18. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
Yamane T; Kaneko A; Mohri M
Int J Clin Oncol; 2004 Apr; 9(2):69-73. PubMed ID: 15108036
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
[TBL] [Abstract][Full Text] [Related]
20. Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.
Francis JH; Barker CA; Wolden SL; McCormick B; Segal K; Cohen G; Gobin YP; Marr BP; Brodie SE; Dunkel IJ; Abramson DH
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):517-23. PubMed ID: 23953635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
